NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Biotechnology · USD

SL Science Holding Limited (SLBT) Stock Analysis

SL Science Holding Limited (SLBT) is a Biotechnology stock listed on NASDAQ and quoted in US Dollar.

SLBT

$2.88

−$0.27 (−8.57%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SLBT with… →

SLBT Key Statistics

As of Sep 4, 2026
Trading
Open
$3.15
Previous Close
$3.15
Day's Range
2.88–3.16
52-Week Range
2.51–14.50
Volume
68.58K
Valuation
Market Cap
$1.61B
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
493.86
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.01
Financials (FY)
Revenue (FY)
$2.20M−34.68%
Net Income (FY)
−$3.82M
Profit marginThe share of revenue left as profit after all costs and taxes.
−72.46%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
560.76M
1-Year Return
−72.07%
Dividend and dates
Avg Volume
745.41K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

SLBT Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−72.69%
2025 (partial year)+5.24%

As of September 4, 2026.

SLBT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$2.20M−$3.82M−173.8%
2024$3.36M−$1.19M−35.4%
2023$878.97K$399.04K45.4%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$2.20M$775.06K−$3.84M−$3.82M−173.8%
2024$3.36M$1.93M−$1.20M−$1.19M−35.4%
2023$878.97K$738.01K$96.83K$399.04K45.4%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SLBT Valuation vs Biotechnology Median

Median of 654 stocks
MetricSLBTBiotechnology medianvs median
P/S ratio493.8615.2632.4x the median
Profit margin−72.46%0.00%72.5 pts below

Medians across 654 Biotechnology stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

SL Science Holding Limited (SLBT) is capitalised at $1.61B on the latest close. The company sits in the Healthcare sector, in the Biotechnology industry. Headcount on file is 14.

Over the past 52 weeks the price has ranged from $2.51 to $14.50. The most recent close on file for SLBT is $2.88, dated September 4, 2026. That is −$0.27 (−8.57%) against the previous close. The latest close sits 14.74% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $2.20M. That is −34.68% against the prior fiscal year, when revenue was $3.36M. The same year closed with a net loss of $3.82M. The reported profit margin is −72.46%. That is 72.5 percentage points below the Biotechnology median of 0%. Earnings per share on a trailing basis come to −0.01.

Across the 3 fiscal years on file, revenue moves from $878.97K in 2023 to $2.20M in 2025. Of those 3 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 493.86 times revenue. On price-to-sales that is 32.4 times the Biotechnology median of 15.26. The medians here are taken across 654 Biotechnology companies that report the metric.

Daily returns over the trailing 1 year annualize to a volatility of 211.28%. Over the trailing twelve months the price has returned −72.07%. The stored price history starts on February 5, 2025, and the total return since then is −71.26%.

Growth & Income

The record shows no dividend for SLBT.

2026 is still running; the price is −72.69% year to date.

Peer Comparison

SL Science Holding Limited (SLBT) operates in the Biotechnology industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
SL Science Holding Limited SLBT $1.61B —
Vertex Pharmaceuticals Incorporated VRTX $138.42B 31.8
Regeneron Pharmaceuticals, Inc. REGN $85.22B 20.5
argenx SE ARGX $64.25B 39.4

The Biotechnology industry average P/E ratio is 12.9x. SL Science Holding Limited has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Biotechnology Stocks

VRTX

Vertex Pharmaceuticals Incorporated

$138.42B

 REGN

Regeneron Pharmaceuticals, Inc.

$85.22B

 ARGX

argenx SE

$64.25B

 MRNA

Moderna, Inc.

$58.11B

 RVMD

Revolution Medicines, Inc.

$45.01B

 ONC

BeOne Medicines AG

$40.53B
View all Biotechnology stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About SL Science Holding Limited

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.

Visit website →